Tapewire

Nasdaq · USD

JAZZ

Jazz Pharmaceuticals plc

Export transactions ↓
Tapewire entity
818
SEC CIK
0001232524
Parsed reports
624

Last 12 months

Inside the activity.

0 purchase rows · 59 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025013
Dec 202503
Jan 202600
Feb 2026015
Mar 202604
Apr 202603
May 202605
Jun 202603
Jul 202601
Aug 202607
Sep 202603
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 03, 2025 Filed Jun 4, 2025 20:50 UTC
COZADD BRUCE CDirector · Chairman & CEO
SaleOrdinary Shares 500 $110.00 $55,000.00
Disclosure

SEC source: 0001765581-25-000044 · edgardoc.xml · nonDerivative · entry 2

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 437,973

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:50 UTC
COZADD BRUCE CDirector · Chairman & CEO
SaleOrdinary Shares 500 $107.90 $53,950.00
Disclosure

SEC source: 0001765581-25-000044 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 438,473

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.

Read SEC document
May 12, 2025 Filed May 13, 2025 22:51 UTC PurchaseOrdinary Shares 1,621 $103.00 $166,961.54
Disclosure

SEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 4

Mulligan Seamus · CIK 0001536639 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Nerano Pharma Lim

Disclosed balance after: 101,621

F4 · price: Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $102.97 to $103.00. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.

F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.

Read SEC document
May 09, 2025 Filed May 13, 2025 22:51 UTC PurchaseOrdinary Shares 100 $99.71 $9,971.00
Disclosure

SEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 3

Mulligan Seamus · CIK 0001536639 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Nerano Pharma Lim

Disclosed balance after: 100,000

F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.

Read SEC document
May 09, 2025 Filed May 13, 2025 22:51 UTC PurchaseOrdinary Shares 19,216 $98.91 $1,900,677.62
Disclosure

SEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 2

Mulligan Seamus · CIK 0001536639 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Nerano Pharma Lim

Disclosed balance after: 99,900

F3 · price: Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $98.56 to $99.47. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.

F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.

Read SEC document
May 09, 2025 Filed May 13, 2025 22:51 UTC PurchaseOrdinary Shares 80,684 $98.10 $7,915,471.55
Disclosure

SEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 1

Mulligan Seamus · CIK 0001536639 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Nerano Pharma Lim

Disclosed balance after: 80,684

F1 · price: Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $97.56 to $98.5542. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.

F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.

Read SEC document
May 02, 2025 Filed May 5, 2025 23:00 UTC
COZADD BRUCE CDirector · Chairman & CEO
SaleOrdinary Shares 500 $120.00 $60,000.00
Disclosure

SEC source: 0001765581-25-000039 · edgardoc.xml · nonDerivative · entry 2

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 438,807

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
May 01, 2025 Filed May 5, 2025 23:00 UTC
COZADD BRUCE CDirector · Chairman & CEO
SaleOrdinary Shares 1,000 $116.35 $116,350.00
Disclosure

SEC source: 0001765581-25-000039 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 439,307

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 21:32 UTC
COZADD BRUCE CDirector · Chairman & CEO
SaleOrdinary Shares 1,500 $123.75 $185,625.00
Disclosure

SEC source: 0001765581-25-000037 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 440,307

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 22:17 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 1,140 $137.81 $157,103.40
Disclosure

SEC source: 0001765581-25-000031 · edgardoc.xml · nonDerivative · entry 2

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,012

Read SEC document
March 10, 2025 Filed Mar 12, 2025 18:24 UTC
Iannone RobertEVP, Global Head of R&D & CMO
SaleOrdinary Shares 2,403 $138.41 $332,604.52
Disclosure

SEC source: 0001765581-25-000035 · edgardoc.xml · nonDerivative · entry 1

Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,621

Read SEC document
March 07, 2025 Filed Mar 7, 2025 23:49 UTC
Iannone RobertEVP, Global Head of R&D & CMO
SaleOrdinary Shares 1,548 $140.00 $216,720.00
Disclosure

SEC source: 0001765581-25-000026 · edgardoc.xml · nonDerivative · entry 3

Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,024

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 07, 2025 Filed Mar 7, 2025 23:49 UTC
Iannone RobertEVP, Global Head of R&D & CMO
SaleOrdinary Shares 5,532 $138.21 $764,577.72
Disclosure

SEC source: 0001765581-25-000026 · edgardoc.xml · nonDerivative · entry 2

Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,572

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.19 to $138.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 22:19 UTC
Henderson Mary ElizabethSVP, Technical Operations
Disposition to issuerOrdinary Shares 698 $138.23 $96,484.54
Disclosure

SEC source: 0001765581-25-000033 · edgardoc.xml · nonDerivative · entry 1

Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,077

F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 22:17 UTC
Carr PatriciaSVP, Chief Accounting Officer
Disposition to issuerOrdinary Shares 1,333 $138.23 $184,260.59
Disclosure

SEC source: 0001765581-25-000031 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,152

F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Read SEC document
March 05, 2025 Filed Mar 8, 2025 00:00 UTC
Pearce SamanthaEVP, Chief Commercial Officer
Disposition to issuerOrdinary Shares 1,905 $138.95 $264,699.75
Disclosure

SEC source: 0001765581-25-000029 · edgardoc.xml · nonDerivative · entry 1

Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,226

F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 23:51 UTC
Johnson Philip LEVP & Chief Financial Officer
Disposition to issuerOrdinary Shares 1,149 $138.95 $159,653.55
Disclosure

SEC source: 0001765581-25-000027 · edgardoc.xml · nonDerivative · entry 1

Johnson Philip L · CIK 0002013156 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,060

F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 23:49 UTC
Iannone RobertEVP, Global Head of R&D & CMO
Disposition to issuerOrdinary Shares 5,239 $138.95 $727,959.05
Disclosure

SEC source: 0001765581-25-000026 · edgardoc.xml · nonDerivative · entry 1

Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,104

F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 23:57 UTC
Patil Neena MEVP & Chief Legal Officer
Disposition to issuerOrdinary Shares 4,088 $138.95 $568,027.60
Disclosure

SEC source: 0001765581-25-000028 · edgardoc.xml · nonDerivative · entry 1

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,526

F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 23:45 UTC
GALA RENEE DPresident & COO
Disposition to issuerOrdinary Shares 5,704 $138.95 $792,570.80
Disclosure

SEC source: 0001765581-25-000025 · edgardoc.xml · nonDerivative · entry 1

GALA RENEE D · CIK 0001607737 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,895

F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 23:43 UTC
COZADD BRUCE CDirector · Chairman & CEO
Disposition to issuerOrdinary Shares 22,251 $138.95 $3,091,776.45
Disclosure

SEC source: 0001765581-25-000024 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 441,807

F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 00:13 UTC
COZADD BRUCE CDirector · Chairman & CEO
SaleOrdinary Shares 6,500 $144.25 $937,625.00
Disclosure

SEC source: 0001765581-25-000006 · edgardoc.xml · nonDerivative · entry 2

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 464,058

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 773 $143.30 $110,767.04
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 8

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,485

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:35 UTC
Pearce SamanthaEVP, Chief Commercial Officer
GrantOrdinary Shares 5,778 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000016 · edgardoc.xml · nonDerivative · entry 2

Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,131

F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:35 UTC
Pearce SamanthaEVP, Chief Commercial Officer
GrantOrdinary Shares 11,941 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000016 · edgardoc.xml · nonDerivative · entry 1

Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,353

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:24 UTC
Johnson Philip LEVP & Chief Financial Officer
GrantOrdinary Shares 7,704 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000012 · edgardoc.xml · nonDerivative · entry 2

Johnson Philip L · CIK 0002013156 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,209

F3 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:24 UTC
Johnson Philip LEVP & Chief Financial Officer
GrantOrdinary Shares 15,407 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000012 · edgardoc.xml · nonDerivative · entry 1

Johnson Philip L · CIK 0002013156 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,505

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

F2 · balance_after: The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 01:22 UTC
Iannone RobertEVP, G R&D and CMO
GrantOrdinary Shares 8,859 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000020 · edgardoc.xml · nonDerivative · entry 2

Iannone Robert · CIK 0001737329 · EVP, G R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,343

F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 01:22 UTC
Iannone RobertEVP, G R&D and CMO
GrantOrdinary Shares 17,718 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000020 · edgardoc.xml · nonDerivative · entry 1

Iannone Robert · CIK 0001737329 · EVP, G R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,484

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 01:19 UTC
Henderson Mary ElizabethSVP, Technical Operations
GrantOrdinary Shares 3,852 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000018 · edgardoc.xml · nonDerivative · entry 2

Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,775

F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 01:19 UTC
Henderson Mary ElizabethSVP, Technical Operations
GrantOrdinary Shares 5,392 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000018 · edgardoc.xml · nonDerivative · entry 1

Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,923

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:29 UTC
GALA RENEE DPresident & COO
GrantOrdinary Shares 11,555 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000014 · edgardoc.xml · nonDerivative · entry 2

GALA RENEE D · CIK 0001607737 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,599

F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:29 UTC
GALA RENEE DPresident & COO
GrantOrdinary Shares 23,111 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000014 · edgardoc.xml · nonDerivative · entry 1

GALA RENEE D · CIK 0001607737 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,044

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 313 $0.00 Strike: $123.36 $0.00
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · derivative · entry 10

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 313 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,500 $0.00 Strike: $113.10 $0.00
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · derivative · entry 9

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 4,500 shares

Expires 2030-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
GrantOrdinary Shares 2,889 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 7

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,258

F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
Disposition to issuerOrdinary Shares 497 $142.43 $70,788.11
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 6

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,369

F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
Disposition to issuerOrdinary Shares 371 $142.43 $52,840.45
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 5

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,866

F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 313 $144.42 $45,202.27
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 4

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,237

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
Exercise / conversionOrdinary Shares 313 $123.36 $38,611.68
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 3

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 4,500 $144.42 $649,872.90
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 2

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,237

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:21 UTC
Carr PatriciaSVP, Chief Accounting Officer
Exercise / conversionOrdinary Shares 4,500 $113.10 $508,950.00
Disclosure

SEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,737

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:18 UTC
Patil Neena MEVP & Chief Legal Officer
GrantOrdinary Shares 5,778 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000008 · edgardoc.xml · nonDerivative · entry 3

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,614

F3 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:18 UTC
Patil Neena MEVP & Chief Legal Officer
GrantOrdinary Shares 12,518 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000008 · edgardoc.xml · nonDerivative · entry 2

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,836

F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:18 UTC
Patil Neena MEVP & Chief Legal Officer
SaleOrdinary Shares 3,800 $144.87 $550,506.00
Disclosure

SEC source: 0001765581-25-000008 · edgardoc.xml · nonDerivative · entry 1

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,318

F1 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.81 to $144.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
February 27, 2025 Filed Mar 4, 2025 00:13 UTC
COZADD BRUCE CDirector · Chairman & CEO
GrantOrdinary Shares 30,814 $0.00 $0.00
Disclosure

SEC source: 0001765581-25-000006 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 470,558

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on March 5, 2026.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 22:41 UTC
COZADD BRUCE CDirector · Chairman & CEO
SaleOrdinary Shares 1,500 $122.31 $183,465.00
Disclosure

SEC source: 0001805688-25-000015 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 439,744

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
January 17, 2025 Filed Jan 22, 2025 23:40 UTC
Pearce SamanthaEVP, Chief Commercial Officer
Tax withholdingOrdinary Shares 1,365 $122.62 $167,376.30
Disclosure

SEC source: 0001805688-25-000003 · edgardoc.xml · nonDerivative · entry 2

Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,412

F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Read SEC document
January 17, 2025 Filed Jan 22, 2025 23:40 UTC
Pearce SamanthaEVP, Chief Commercial Officer
GrantOrdinary Shares 2,533 $0.00 $0.00
Disclosure

SEC source: 0001805688-25-000003 · edgardoc.xml · nonDerivative · entry 1

Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,777

F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified.

F2 · balance_after: The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024.

Read SEC document
January 17, 2025 Filed Jan 22, 2025 23:58 UTC
Iannone RobertEVP, G R&D and CMO
Tax withholdingOrdinary Shares 2,181 $122.62 $267,434.22
Disclosure

SEC source: 0001805688-25-000013 · edgardoc.xml · nonDerivative · entry 2

Iannone Robert · CIK 0001737329 · EVP, G R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,766

F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.